H2O2-independent chemodynamic therapy initiated from magnetic iron carbide nanoparticle-assisted artemisinin synergy

Author:

Zhao Fan12,Yu Jing12ORCID,Gao Weiliang12,Yang Xue3,Liang Liying12,Sun Xiaolian4,Su Dan5,Ying Yao12ORCID,Li Wangchang12,Li Juan12,Zheng Jingwu12,Qiao Liang12,Cai Wei12,Che Shenglei12ORCID,Mou Xiaozhou3

Affiliation:

1. College of Materials Science and Engineering, Zhejiang University of Technology, Hangzhou 310014, China

2. Research Center of Magnetic and Electronic Materials, Zhejiang University of Technology, Hangzhou 310014, China

3. Clinical Research Institute, Zhejiang Provincial People's Hospital, Hangzhou 310014, China

4. Key Laboratory of Drug Quality Control and Pharmacovigilance (China Pharmaceutical University), Ministry of Education, Nanjing 210009, China

5. Department of Oncology, Zhejiang Provincial People's Hospital, Hangzhou 310014, China

Abstract

Chemodynamic therapy (CDT) is a booming technology that utilizes Fenton reagents to kill tumor cells by transforming intracellular H2O2 into reactive oxygen species (ROS), but insufficient endogenous H2O2 makes it difficult to attain satisfactory antitumor results.

Funder

National Natural Science Foundation of China

Natural Science Foundation of Zhejiang Province

Department of Health of Zhejiang Province

Publisher

Royal Society of Chemistry (RSC)

Subject

General Chemical Engineering,General Chemistry

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3